Acute lymphoblastic leukaemia in puberty and adolescence.
van den Berg
H
H
Department of Paediatric Oncology, Emma Children Hospital AMC, Amsterdam, The Netherlands. h.vandenberg@amc.uva.nl
van der Lelie
J
J
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D017668:Age of Onset; D000782:Aneuploidy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000493:pharmacokinetics / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D019090:Case Management; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D050676:Core Binding Factor Alpha 2 Subunit; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007223:Infant; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000032:analysis / Q000235:genetics; D010677:Philadelphia Chromosome; D010820:Physicians / Q000523:psychology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000378:metabolism; D011379:Prognosis; D011627:Puberty; D012307:Risk Factors; D014178:Translocation, Genetic; D016896:Treatment Outcome; D000097764:ETS Translocation Variant 6 Protein
D014408:Biomarkers, Tumor; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; C102421:TEL-AML1 fusion protein; D000097764:ETS Translocation Variant 6 Protein